Robert Iannone, M.D., M.S.C.E
2021
Compensation breakdown
| Non-Equity Incentive Plan | $380,000 |
|---|---|
| Salary | $591,923 |
| Stock Awards | $3,018,091 |
| Other | $11,322 |
| Total | $4,001,336 |
MSCE received $3M in stock awards, accounting for 75% of the total pay in 2021.
MSCE also received $380K in non-equity incentive plan, $591.9K in salary and $11.3K in other compensation.
Rankings
In 2021, Robert Iannone, M.D., M.S.C.E's compensation ranked 3,345th out of 12,406 executives tracked by ExecPay. In other words, MSCE earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,345 out of 12,406 | 73rd |
Division Manufacturing | 1,359 out of 5,492 | 75th |
Major group Chemicals And Allied Products | 553 out of 2,368 | 77th |
Industry group Drugs | 492 out of 2,089 | 76th |
Industry Pharmaceutical Preparations | 340 out of 1,536 | 78th |
Pay ratio
| Robert Iannone, M.D., M.S.C.E's Pay | $4,001,336 |
|---|---|
| Median Employee's Pay | $212,134 |
| Pay Ratio | 19to 1 |
In 2021, the annual total compensation of Robert Iannone, M.D., M.S.C.E was $4,001,336.
The annual total compensation of the median employee at Jazz Pharmaceuticals was $212,134.
The ratio of Robert Iannone, M.D., M.S.C.E's pay to the pay of median employee was therefore 19 to one.
MSCE's colleagues
We found four more compensation records of executives who worked with Robert Iannone, M.D., M.S.C.E at Jazz Pharmaceuticals in 2021.